vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与QCR HOLDINGS INC（QCRH）财务数据对比。点击上方公司名可切换其他公司
QCR HOLDINGS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$107.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 16.5%），QCR HOLDINGS INC自由现金流更多（$354.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -13.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
QCR控股有限公司通过旗下子公司，为阔德城和锡达拉皮兹地区的客户提供商业与零售银行服务，以及信托和资产管理服务。公司成立于1993年，总部位于伊利诺伊州莫林市。
PBYI vs QCRH — 直观对比
营收规模更大
QCRH
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出11.2%
16.5%
自由现金流更多
QCRH
多$339.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
-13.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $107.0M |
| 净利润 | — | — |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 36.1% |
| 净利率 | — | — |
| 营收同比 | 27.7% | 16.5% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $2.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIQCRH
| Q4 25 | $75.5M | $107.0M | ||
| Q3 25 | $54.5M | $101.5M | ||
| Q2 25 | $52.4M | $84.2M | ||
| Q1 25 | $46.0M | $76.9M | ||
| Q4 24 | $59.1M | $91.8M | ||
| Q3 24 | $80.5M | $152.6M | ||
| Q2 24 | $47.1M | $150.6M | ||
| Q1 24 | $43.8M | $141.9M |
净利润PBYIQCRH
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $36.7M | ||
| Q2 25 | $5.9M | $29.0M | ||
| Q1 25 | $3.0M | $25.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $27.8M | ||
| Q2 24 | $-4.5M | $29.1M | ||
| Q1 24 | $-4.8M | $26.7M |
毛利率PBYIQCRH
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIQCRH
| Q4 25 | 22.7% | 36.1% | ||
| Q3 25 | 17.6% | 40.0% | ||
| Q2 25 | 12.7% | 36.3% | ||
| Q1 25 | 8.7% | 34.0% | ||
| Q4 24 | 22.6% | 36.1% | ||
| Q3 24 | 27.4% | 19.6% | ||
| Q2 24 | -4.6% | 21.0% | ||
| Q1 24 | -5.3% | 19.7% |
净利率PBYIQCRH
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 36.2% | ||
| Q2 25 | 11.2% | 34.5% | ||
| Q1 25 | 6.5% | 33.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 18.2% | ||
| Q2 24 | -9.6% | 19.3% | ||
| Q1 24 | -11.0% | 18.8% |
每股收益（稀释后）PBYIQCRH
| Q4 25 | $0.26 | $2.10 | ||
| Q3 25 | $0.17 | $2.16 | ||
| Q2 25 | $0.12 | $1.71 | ||
| Q1 25 | $0.06 | $1.52 | ||
| Q4 24 | $0.40 | $1.77 | ||
| Q3 24 | $0.41 | $1.64 | ||
| Q2 24 | $-0.09 | $1.72 | ||
| Q1 24 | $-0.10 | $1.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.1B |
| 总资产 | $216.3M | $9.6B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIQCRH
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYIQCRH
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIQCRH
| Q4 25 | $130.3M | $1.1B | ||
| Q3 25 | $115.3M | $1.1B | ||
| Q2 25 | $104.7M | $1.1B | ||
| Q1 25 | $97.1M | $1.0B | ||
| Q4 24 | $92.1M | $997.4M | ||
| Q3 24 | $71.1M | $976.6M | ||
| Q2 24 | $48.5M | $936.3M | ||
| Q1 24 | $51.0M | $907.3M |
总资产PBYIQCRH
| Q4 25 | $216.3M | $9.6B | ||
| Q3 25 | $202.9M | $9.6B | ||
| Q2 25 | $194.9M | $9.2B | ||
| Q1 25 | $196.2M | $9.2B | ||
| Q4 24 | $213.3M | $9.0B | ||
| Q3 24 | $220.7M | $9.1B | ||
| Q2 24 | $205.0M | $8.9B | ||
| Q1 24 | $214.1M | $8.6B |
负债/权益比PBYIQCRH
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $421.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $354.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 330.9% |
| 资本支出强度资本支出/营收 | 0.0% | 63.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $397.4M |
8季度趋势，按日历期对齐
经营现金流PBYIQCRH
| Q4 25 | $14.4M | $421.5M | ||
| Q3 25 | $9.7M | $47.5M | ||
| Q2 25 | $14.1M | $42.2M | ||
| Q1 25 | $3.6M | $-3.6M | ||
| Q4 24 | $15.6M | $444.5M | ||
| Q3 24 | $11.0M | $238.1M | ||
| Q2 24 | $1.0M | $26.3M | ||
| Q1 24 | $11.2M | $2.7M |
自由现金流PBYIQCRH
| Q4 25 | $14.4M | $354.1M | ||
| Q3 25 | $9.7M | $31.7M | ||
| Q2 25 | $14.1M | $24.2M | ||
| Q1 25 | $3.6M | $-12.7M | ||
| Q4 24 | $15.6M | $400.0M | ||
| Q3 24 | $11.0M | $229.9M | ||
| Q2 24 | $1.0M | $16.2M | ||
| Q1 24 | — | $-9.4M |
自由现金流率PBYIQCRH
| Q4 25 | 19.1% | 330.9% | ||
| Q3 25 | 17.7% | 31.3% | ||
| Q2 25 | 26.8% | 28.8% | ||
| Q1 25 | 7.7% | -16.5% | ||
| Q4 24 | 26.4% | 435.6% | ||
| Q3 24 | 13.7% | 150.7% | ||
| Q2 24 | 2.1% | 10.7% | ||
| Q1 24 | — | -6.6% |
资本支出强度PBYIQCRH
| Q4 25 | 0.0% | 63.0% | ||
| Q3 25 | 0.0% | 15.5% | ||
| Q2 25 | 0.0% | 21.4% | ||
| Q1 25 | 0.1% | 11.9% | ||
| Q4 24 | 0.0% | 48.4% | ||
| Q3 24 | 0.0% | 5.4% | ||
| Q2 24 | 0.0% | 6.8% | ||
| Q1 24 | 0.0% | 8.6% |
现金转化率PBYIQCRH
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 1.29× | ||
| Q2 25 | 2.41× | 1.46× | ||
| Q1 25 | 1.21× | -0.14× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 8.57× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | — | 0.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
